Frontiers in Oncology (Feb 2022)
Corrigendum: A Recombinant Human Adenovirus Type 5 (H101) Combined With Chemotherapy for Advanced Gastric Carcinoma: A Retrospective Cohort Study
Abstract
No abstracts available.Keywords
Frontiers in Oncology (Feb 2022)